Related references
Note: Only part of the references are listed.Discovery of endogenous inverse agonists for G protein-coupled receptor 6
Sarah H. Shrader et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Discovery of novel N-sulfonamide-tetrahydroquinolines as potent retinoic acid receptor-related orphan receptor γt inverse agonists for the treatment of autoimmune diseases
Nannan Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
The atomistic level structure for the activated human.-opioid receptor bound to the full Gi protein and the MP1104 agonist
Amirhossein Mafi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Discovery of [1,2,4]Triazolo[1,5-a]pyridine Derivatives as Potent and Orally Bioavailable RORγt Inverse Agonists
Ryota Nakajima et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
delta Opioid Receptor Inverse Agonists and their In Vivo Pharmacological Effects
Shigeto Hirayama et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Optimization and biological evaluation of thiazole-bis-amide inverse agonists of RORγt
Christian Gege et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Discovery of δ opioid receptor full agonists lacking a basic nitrogen atom and their antidepressant-like effects
Hideaki Fujii et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
Jerome Amaudrut et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
The Discovery of LML134, a Histamine H3 Receptor Inverse Agonist for the Clinical Treatment of Excessive Sleep Disorders
Thomas Troxler et al.
CHEMMEDCHEM (2019)
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer
Yan Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists
Zhonghui Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
3-Substituted Quinolines as RORγt Inverse Agonists
Virginia M. Tanis et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Discovery and pharmacological evaluation of indole derivatives as potent and selective ROR gamma t inverse agonist for multiple autoimmune conditions
Nadim S. Shaikh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Functionalized 6-(Piperidin-1-yl)-8,9-Diphenyl Purines as Peripherally Restricted Inverse Agonists of the CB1 Receptor
George Amato et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Development of Novel δ Opioid Receptor Inverse Agonists without a Basic Nitrogen Atom and Their Antitussive Effects in Mice
Eika Higashi et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Design and Synthesis of Conformationally Constrained RORγt Inverse Agonists
Ayumu Sato et al.
CHEMMEDCHEM (2019)
Discovery of Novel μ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening
Giulio Poli et al.
MOLECULES (2019)
Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting Activity
Ramakrishna Nirogi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer
Jina Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of δ Opioid Receptor Full Inverse Agonists and Their Effects on Restraint Stress-Induced Cognitive Impairment in Mice
Shigeto Hirayama et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Tao Che et al.
CELL (2018)
Structure of the μ-opioid receptor-Gi protein complex
Antoine Koehl et al.
NATURE (2018)
C-Homomorphinan Derivatives as Lead Compounds to Obtain Safer and More Clinically Useful Analgesics
Kyoko Ishikawa et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Naltrindole derivatives with fluorinated ethyl substituents on the 17-nitrogen as δ opioid receptor inverse agonists
Toru Nemoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Structural insights into μ-opioid receptor activation
Weijiao Huang et al.
NATURE (2015)
Molecular control of δ-opioid receptor signalling
Gustavo Fenalti et al.
NATURE (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Structure of the δ-opioid receptor bound to naltrindole
Sebastien Granier et al.
NATURE (2012)
Crystal structure of the μ-opioid receptor bound to a morphinan antagonist
Aashish Manglik et al.
NATURE (2012)
Identification of the three-dimensional pharmacophore of κ-opioid receptor agonists
Noriyuki Yamaotsu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field
Devleena Shivakumar et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2010)
Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution
Jeremy R. Greenwood et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Novel cleavage reaction of the C16-N17 bond in naltrexone derivatives
Hideaki Fujii et al.
TETRAHEDRON LETTERS (2008)
Epik:: a software program for pK a prediction and protonation state generation for drug-like molecules
John C. Shelley et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery
RA Bond et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Constitutive receptor activity series historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors
T Costa et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists
PJ Emmerson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Salvinorin A:: A potent naturally occurring nonnitrogenous κ opioid selective agonist
BL Roth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The use of constitutively active GPCRs in drug discovery and functional genomics
DT Chalmers et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5α-epoxy-3,14-dihydroxy-6,7:2′,3′-indolomorphinans, on opioid receptor affinity, selectivity, and efficacy
S McLamore et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Share Paper
